Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer | AAPG Stock NewsStockTitan·1 day ago, 10:30 AMAAPG-3.56%06855-3.37%
Hong Kong Niche Equities Diverge: The Latest on C&D International and KepeiGlobal Report·Jul 30 at 04:13 AM01890-3.33%01920+2.25%
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026 | AAPG Stock NewsStockTitan·Jul 26 at 10:30 AMAAPG-3.56%
Ascentage Pharma Sets Up US$200 Million Nasdaq ATM Offering Following SEC Shelf FilingTip Ranks·Jul 20 at 07:48 AMAAPG-3.56%06855-3.37%
ASCENTAGE Plans ATM Offering of ADSs in US to Raise Up to USD200 millionAASTOCKS News·Jul 19 at 08:10 PMAAPG-3.56%06855-3.37%
Ascentage Pharma Sets Up $200 Million Nasdaq ATM Offering ProgramTip Ranks·Jul 19 at 06:37 AM06855-3.37%AAPG-3.56%
Ascentage Pharma files for Nasdaq at-the-market ADS offering up to US$200 millionPUBT·Jul 19 at 06:19 AM06855-3.37%AAPG-3.56%
Ascentage Pharma Corrects AGM Date Underpinning Equity Incentive MandateTip Ranks·Jul 13 at 07:48 PM06855-3.37%AAPG-3.56%
Ascentage Pharma corrects AGM date tied to RSU, option grant mandate to May 19, 2025PUBT·Jul 13 at 03:48 PM06855-3.37%AAPG-3.56%
Ascentage Pharma corrects AGM date tied to 2021/2022 RSU awards and post-IPO option grantsPUBT·Jul 12 at 07:02 PM06855-3.37%AAPG-3.56%
Ascentage Pharma grants 3,223,685 RSUs under 2022 employee share schemePUBT·Jun 30 at 03:16 PM06855-3.37%
Ascentage Pharma Grants New RSUs to 453 Employees Under 2021 SchemeTip Ranks·Jun 29 at 06:07 PM06855-3.37%
